Table 2.

Utility scores at baseline and follow-up for the EQ-5D individual mapping algorithm

	IDeg		IGlar
Study id	Baseline	End-of-trial	Baseline	End-of-trial
3582 [17]	0.8843 ± 0.0931	0.8837 ± 0.0977	0.8858 ± 0.0948	0.8784 ± 0.0933
3583 [18]	0.9436 ± 0.0636	0.9430 ± 0.0599	0.9414 ± 0.0607	0.9342 ± 0.0711
3579 [19]	0.8958 ± 0.0867	0.9009 ± 0.0894	0.8951 ± 0.0912	0.8933 ± 0.0945
3586 [23]	0.9208 ± 0.0575	0.9286 ± 0.0618	0.9211 ± 0.0632	0.9273 ± 0.0566
3668 [24]	0.8958 ± 0.0797	0.9030 ± 0.779	0.8921 ± 0.0810	0.8972 ± 0.0912
3672 [25]	0.8957 ± 0.0887	0.9080 ± 0.0810	0.8889 ± 0.0858	0.8963 ± 0.0912

Values are mean ± standard deviation.

IDeg, insulin degludec; IGlar, insulin glargine.